(Q45832731)

16 December 2017

title

False-positive results of screening for antibodies to human immunodeficiency virus in chronic hemodialysis patients (English)

1 reference

16 December 2017

1 reference

Arnow PM

1

1 reference

16 December 2017

Fellner S

series ordinal

2

1 reference

16 December 2017

Harrington R

series ordinal

3

1 reference

16 December 2017

Leuther M

series ordinal

4

1 reference

16 December 2017

publication date

1 May 1988

1 reference

16 December 2017

American Journal of Kidney Diseases

published in

1 reference

16 December 2017

volume

11

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

page(s)

383-386

1 reference

16 December 2017

Dialysis in AIDS patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

HTLV-III/LAV infection in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

More on AIDS in patients on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Prevalence of human T-lymphotropic virus type III antibodies among patients in dialysis programs at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Prevalence of human immunodeficiency virus antibodies and hepatitis B markers among patients having hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

LAV/HTLV-III and HTLV-I antibodies in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2888%2980050-7

7 January 2021

10.1016/S0272-6386(88)80050-7

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017